No abstract available
Keywords:
CTLA-4; PD1; PDL1; immunotherapy; melanoma.
MeSH terms
-
Animals
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials as Topic
-
Female
-
Humans
-
Ipilimumab / therapeutic use*
-
Male
-
Melanocytes / pathology*
-
Melanoma / immunology
-
Melanoma / pathology
-
Melanoma / therapy*
-
Mucous Membrane / pathology*
-
Neoplasm Metastasis
-
Nose Neoplasms / immunology
-
Nose Neoplasms / pathology
-
Nose Neoplasms / therapy*
-
Programmed Cell Death 1 Receptor / immunology
-
Skin Neoplasms / immunology
-
Skin Neoplasms / pathology
-
Skin Neoplasms / therapy*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Ipilimumab
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor